APA (7th ed.) Citation

EE, G., TM, Q., A, M., AM, B., J, A., AC, M., . . . K, D. (2023). An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE). American journal of respiratory and critical care medicine, 207(2), 138. https://doi.org/10.1164/rccm.202203-0477OC

Chicago Style (17th ed.) Citation

EE, Gaughan, et al. "An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)." American Journal of Respiratory and Critical Care Medicine 207, no. 2 (2023): 138. https://doi.org/10.1164/rccm.202203-0477OC.

MLA (9th ed.) Citation

EE, Gaughan, et al. "An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)." American Journal of Respiratory and Critical Care Medicine, vol. 207, no. 2, 2023, p. 138, https://doi.org/10.1164/rccm.202203-0477OC.